SEC Form 4 · accession 0000740260-17-000062

Ventas, Inc. · VTR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, Medical Prop. Operations

Period of report

Feb 28, 2017

Accepted (ET)

Mar 2, 2017 · 4:47 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000740260

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 28, 2017	M	9,459	$45.03	A	144,997	D
Common Stock^F1	Feb 28, 2017	S	9,459	$65.0227	D	135,538	D
Common Stock	Feb 28, 2017	M	29,631	$46.88	A	165,169	D
Common Stock^F1	Feb 28, 2017	S	29,631	$65.0227	D	135,538	D
Common Stock	Feb 28, 2017	M	32,058	$55.50	A	167,596	D
Common Stock^F1	Feb 28, 2017	S	32,058	$65.0227	D	135,538	D
Common Stock	Feb 28, 2017	M	71,211	$51.85	A	206,749	D
Common Stock^F1,F2	Feb 28, 2017	S	71,211	$65.0227	D	135,572	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F3	$45.03	Feb 28, 2017	M	9,459	A	Jan 20, 2011	Jan 20, 2021	Common Stock	9,459	455,418	D
Stock Option (Right to Buy)^F3	$46.88	Feb 28, 2017	M	29,631	A	Jan 18, 2012	Jan 18, 2022	Common Stock	29,631	425,787	D
Stock Option (Right to Buy)^F3	$55.50	Feb 28, 2017	M	32,058	A	Jan 23, 2013	Jan 23, 2023	Common Stock	32,058	393,729	D
Stock Option (Right to Buy)^F3	$51.85	Feb 28, 2017	M	71,211	A	Jan 29, 2014	Jan 29, 2024	Common Stock	71,211	322,518	D

F1On February 28, 2017, the Reporting Person transmitted to the Securities and Exchange Commission (the "SEC") a Form 144 covering the sale of the Issuer's common stock reported in Table I. The price reported in column 4 is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $65.00 to $65.185, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1).
F2Includes 34.203 shares acquired between January 18, 2017 and February 28, 2017 under the Ventas Employee and Director Stock Purchase Plan.
F3These options were part of a previously reported grant by the Issuer to the Reporting Person which vested in three equal annual installments beginning on the date of grant.